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CRUCIATE-RETAINING VERSUS POSTERIOR-STABILIZED PRIMARY 1 
TOTAL ARTHROPLASTY. CLINICAL OUTCOME COMPARISON WITH A 2 
MINIMUM FOLLOW-UP OF 10 YEARS. 3 
 4 
ABSTRACT 5 
Background: Controversy continues regarding whether the posterior cruciate ligament 6 
should be retained or removed during total knee arthroplasty (TKA) procedure. The 7 
objective was to compare the clinical outcomes with a minimum follow-up of 10 years 8 
between patients who received contemporary cruciate retaining (CR) or posterior 9 
stabilized (PS) primary TKA. 10 
Methods: Case-control study of 268 patients underwent CR TKA versus 211 to PS 11 
design, with the same arthroplasty system, and a minimum follow-up of 10 years. 12 
Clinical assessment was performed by Knee Society scores, Western Ontario and 13 
MacMasters Universities and Short-Form 12 questionnaires, range of motion, and 14 
patient satisfaction.  15 
Results: Successful outcomes were found for both designs. No significant differences in 16 
functional scores, range of motion, patient-related scores or patient satisfaction. 17 
Between the 5-year and last postoperative follow-up, there were a significant decrease 18 
of all clinical scores in both groups. In addition, complication rate and implant survival 19 
were similar between groups. 20 
Conclusion: The superiority of one design over the other was not found. Both designs 21 
can be used expecting long-term successful outcomes and high survival. The choice of 22 
the design depended on the status of the posterior cruciate ligament and surgeon 23 
preference. 24 
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outcome; Patient satisfaction. 26 
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INTRODUCTION 29 
Total knee arthroplasty (TKA) has provided high rate of successful outcomes in patients 30 
with end-stage knee osteoarthritis [1]. Several designs have been developed to improve 31 
the durability and function of this procedure. However, the most widely used designs 32 
for primary arthroplasty have been, and continue to be today, cruciate–retaining (CR) 33 
and posterior-stabilized (PS) [2]. Currently, controversy still continues regarding 34 
whether the posterior cruciate ligament (PCL) should be retained or removed during the 35 
procedure [3]. Advantages and disadvantages for both CR and PS designs have been 36 
reported in numerous biomechanical and kinematic studies [4-7]. However, the impact 37 
of the kinematic differences on the clinical outcomes has been controversial, and the 38 
superiority of one design over the other has not been unequivocally demonstrated in 39 
vivo [8].  40 
There were a large number of publications examining the clinical differences between 41 
CR and CS designs, but most of them had small size and a follow-up as short as 5 years 42 
and the findings on clinical outcomes were controversial [9-12]. As far as we know, 43 
only 3 studies have reported comparative clinical outcomes with a minimum follow-up 44 
of 10 years [13-15]. One of these [13] was a randomized study of 62 patients at 2 years 45 
and then reviewed at 10 years where the authors reported similar ROM and functional 46 
outcomes. The 2 other were retrospective comparative studies with follow-up of 10 47 
years, one of which  reported better ROM and function in the PS group [14], and the 48 
other better ROM in PS group but similar functional scores [15]. Thus, evidences on 49 
long-term functional outcomes are limited and controversial. Several systematic reviews 50 
comparing both designs have reported no significant clinical differences with the 51 
available evidences [3,8], and the authors suggested that longer follow-up investigations 52 
were needed. 53 
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The main purpose of this study was to compare the clinical outcomes with a minimum 54 
follow-up of 10 years between patients who received contemporary CR or PS primary 55 
total knee arthroplasty. We hypothesized that long-term outcomes are similar. 56 
 57 
PATIENTS AND METHODS 58 
This long-term retrospective case-control study was approved by our institutional 59 
review board and informed consent was required to perform a new patient evaluation.  60 
A search to identify patients underwent CR and PS primary TKA between 2001 and 61 
2006 was performed on the departmental arthroplasty database using diagnostic and 62 
surgical codes. The inclusion criterion was primary TKA. The exclusion criteria were 63 
diagnosis of posttraumatic or inflammatory arthritis, if bone grafting was required, 64 
varus/valgus deformity greater than 15º, or prior knee osteotomy. 65 
Six hundred and ten patients meeting the criteria were identified. Of them, 82 (13.4%) 66 
patients were excluded for death within 10 postoperative years unrelated to the TKA (38 67 
CR and 44 PS), 31 could not be contacted or they were unable to return for re-68 
evaluation (17 CR and 14 PS), and 18 refused to participate in a new evaluation (12 CR 69 
and 6 PS). Among the remaining 479 patients, 268 received CR and 211 PS 70 
artrhoplasty. In that time, the indication of one or the other TKA design depended on 71 
intraoperative PCL status, and the first years also on preference of the surgeon. Baseline 72 
characteristics at the time of the TKA in both groups are shown in Table 1. There were 73 
no significant differences in preoperative data between groups. 74 
 75 
Operative protocol 76 
The operations were performed by several experienced surgeons, according to the 77 
standardized practice in our center. All procedures were performed in operating room 78 
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with laminar flow, under spinal anaesthesia. A standard anterior midline skin incision 79 
and medial parapatellar arthrotomy was used in all patients. Standard operative 80 
techniques were used for all patients with the respective instrument systems.  81 
The same modular TKA systems were used in all patients (Trekking, Samo, Italy).  The 82 
two designs (CR and PS) were identical except for the cam-post mechanism. CR design 83 
had hybrid fixation (cementless femoral component) and PS design cemented fixation 84 
of both components. Tibial preparation was performed first, and intramedullary 85 
alignments were used for femur and tibia in all patients. Care was taken during bone 86 
resections to balance flexion and extension gaps. All patellae were routinely resurfaced 87 
with an all-polyethylene cemented design. After intraoperative assessment, all patients 88 
with sufficient PCL received CR TKA. Among patients receiving PS TKA, 26 had 89 
sufficient PCL and the remaining 185 had insufficient PCL. 90 
According to the standard protocol, all patients received antibiotic prophylaxis with first 91 
generation cephalosporin for 24 hours (started 1 hour prior to skin incision) and 92 
thromboembolic prophylaxis with low-molecular-weight heparin for 30 days. 93 
Standardized at our centre, continuous passive knee motion started on the first 94 
postoperative day and from the third day active motion under the supervision of the 95 
therapist and full weight-bearing were allowed. 96 
 97 
Evaluations 98 
At our institution, the arthroplasty register prospectively collects clinical and 99 
radiographic data on all patients treated with arthroplasty with a minimum follow-up of 100 
5 years. Standardized assessment was performed preoperatively and postoperatively at 101 
1, 3, 6 months, and then yearly until at least 5 years. For this study, those patients with a 102 
follow-up less than 10 years were invited to return for a new clinical and radiological 103 
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evaluation. For clinical evaluations, the Knee Society scores (KSS) [16], reduced 104 
Western Ontario and MacMasters Universities (WOMAC) [17] and Short-Form 12 105 
(SF12) [18] questionnaires were used. The range of motion (ROM) of the knee joint 106 
was assessed with a standard goniometer. Flexion and extension lag items were also 107 
analyzed separately from KSS. The WOMAC was transformed to a 0-100 scale, so a 108 
higher value implies a better outcome. In addition, patient satisfaction was evaluated at 109 
final follow-up by a 0-10 visual analogue scale (VAS).  110 
Radiological evaluation was performed using standard standing anterior-posterior, 111 
lateral and skyline views. The latest radiographs were analyzed by two independent 112 
surgeons who did not know the clinical evaluations of the patients. The Knee Society 113 
radiographic evaluation system [19] was used for position of components and zones of 114 
radiolucency or osteolysis. Loosening of the arthroplasty was defined by continuous or 115 
progressive radiolucent lines or by migration of any component. 116 
 117 
Statistical analysis 118 
Statistical analyses were performe with SPSS software v. 15.0 (SPSS Inc., Chicago, 119 
USA). Normal distribution was determined by the Kolmogorov-Smirnov test. 120 
Comparisons between categorical variables were made with chi-square test or non-121 
parametric Fisher exact test or Mantel-Haenszel test, and for continuous variables with 122 
Student t-test or Mann-Whitney U-test. Comparisons between preoperative and last 123 
follow-up data were made by paired t-test or Wilcoxon signed-rank test.  Multivariate 124 
analyses by logistic regression models were used to analyze independent factors 125 
affecting final ROM and KSS scores. These data were presented as Odds ratio (OR) 126 
with 95% confidence interval (CI). Kaplan-Meier test was used for TKA survival 127 
analysis with revision for any reason as end-point, and comparison between groups was 128 
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made by the Mantel-Haenszel log-rank test. Significance was considered for p values 129 
less than 0.05 in all tests. 130 
 131 
RESULTS 132 
Mean final follow-up from index TKA to the last assessment was 13.4 (range, 10-15) 133 
years in the CR group, and 12.7 (range, 10-15) years in the PS group. All clinical scores 134 
significantly improved from preoperative to last follow-up in both groups (p= 0.001).  135 
Over the time, there were no significant differences (all, p<0.05) in any functional 136 
outcome between 3 and 5 postoperative years in both groups. Between 5 and 8 137 
postoperative years, there were significant decreases in KSS-knee (p= 0.044) in both 138 
groups and extension lag (p= 0.032) in only CR group, and no significant differences in 139 
KSS-function (p= 0.395) or knee flexion (p= 0.128) in both groups. Between 5 140 
postoperative years and final follow-up (Table 2), there were significant decreases in 141 
both groups for all functional scores except extension lag in the PS group. However, all 142 
these differences in numbers were small. 143 
At the final follow-up, there were no significant differences in any KSS score or ROM 144 
between groups at either 5 postoperative years or final follow-up (Table 2). Multivariate 145 
analysis showed that only preoperative ROM had significant influence on last ROM 146 
(OR: 1.7; 95% IC: 1.1-2.3; p= 0.026), and TKA design had not influence (OR: 0.9; 147 
95%IC: 0.3-3.7; p= 0.394). Likewise, TKA design had not significant influence on last 148 
KSS-knee score (OR: 0.3; 95%IC: 0.02-2.8; p= 0.514) or KSS-function score (OR: 1.1; 149 
95%IC: 0.07-2.7; p= 0.613). 150 
Regarding to the patient-reported outcomes, there were no significant differences over 151 
the time between 3, 5 and 8 postoperative years in both groups (all, p < 0.05). However, 152 
significant differences in both groups were found between 5 postoperative years and the 153 
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final follow-up (Table 3) in SF-12 scores (all, p= 0.001). There was no significant 154 
change in WOMAC score between 5-year follow-up and final in either group. At final 155 
follow-up, there were no significant differences between groups in any patient-reported 156 
scores.  157 
The 86 % of patients in the CR group and 84% in the PS group were satisfied with the 158 
functional outcome of their knees after 10 postoperative years (p= 0.565). At final 159 
follow-up, there was no significant difference between groups in the level of VAS-160 
satisfaction (p= 0.151). There were no significant differences in patient rate with 161 
residual pain knee between groups (8% in CR group versus 6% in PS group, p= 0.547). 162 
A higher patient rate in the PS group reported a greater frequency of swelling or 163 
tightness of their replaced knee than patients in CR group (12% versus 7%), but this 164 
difference was not significant (p= 0.109). 165 
In the CR group, 7 unrevised knees had nonprogressive, incomplete radiolucent line less 166 
than 1 mm in at least 1 zone around the tibial component (zones 1, 3, 4), while in the PS 167 
group this was in 5 unrevised knees (zones 1 and 4). No radiolucent lines around the 168 
femoral or patellar component were found in either group. 169 
Overall, there were 21 (5.5%) revisions, 9 (4.2%) in the CR group and 12 (7.2%) in the 170 
PS group (p= 0.259). There were no revisions of CR due to PCL deficiency. 171 
Complications with subsequent revisions included 3 early wound deep infections (1 CR 172 
and 2 PS) that were treated with 2-stage revisions, 9 aseptic tibial loosening (4 CR and 5 173 
PS) with a time revision ranged from 4 to 9 years, 5 polyethylene insert wear (2 CR and 174 
3 PS) with a time revision ranged from 4 to 8 years of which 2 were treated with only 175 
insert exchanges and the 3 other with tibial revision, and 4 periprosthetic femoral 176 
fracture (2 CR and 2 PS) at 4-9 years of which 3 were treated with retrograde 177 
intramedullar nail and the another with arthroplasty revision. The cumulative survival of 178 
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the TKA at 14-year for any reason (Fig. 1) was 95.7 % (95% CI, 93.0–98.5 %) in the 179 
CR group and 92.7 % (95% CI, 88.8-96.7 %) in the PS group, and this difference was 180 
not significant (log rank, p= 0.209). 181 
 182 
DISCUSSION 183 
Currently, controversy regarding to the advantages and disadvantages of CR and PS 184 
designs continue, and the clinical superiority of one design over the other has still not 185 
been demonstrated [3]. The main objective of the present study was to compare long-186 
term clinical outcomes between both designs. The main findings were successful 187 
outcomes for both CR and PS arthroplasties, with no significant differences at a 188 
minimum postoperative follow-up of 10 years in functional scores, ROM, patient-189 
related scores or patient satisfaction. Between the 5-year and final postoperative follow-190 
up, there were a significant decrease of all clinical scores in both groups, although the 191 
differences in numbers were small. In addition, complication rate and implant survival 192 
were similar between groups. 193 
Potential advantages of CR designs include more normal knee kinematics, especially 194 
increased femoral rollback on the tibia during flexion, intact PCL preventing anterior 195 
translation of the femur on the tibia, greater inherent stability of the prosthesis, 196 
increased proprioception, greater passive knee range of motion (ROM), enhanced 197 
quadriceps muscle power, preservation of bone, and less blood loss [20,21]. On the 198 
other hand, with PS designs have been reported advantages such as greater ease of 199 
balancing of soft tissues, more congruent articulations, increased rollback with reduced 200 
posterior tibial subluxation and greater range of flexion, and superior patellofemoral 201 
kinematics [6,22,23]. 202 
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There were a large number of studies comparing clinical differences between CR and 203 
CS designs, but few of them had a follow-up of 10 years. Scott et al [12], in a 204 
randomized study compared 55 patients who received a CR design and 56 PS design 205 
with mean follow-up of 4 years, reported similar clinical and radiographic outcomes 206 
between both, although the PS patients received significantly more transfusions than CS 207 
patients. However, other studies have reported no difference in blood loss between CR 208 
and PS designs [24] or higher blood loss with the design [25]. In other randomized 209 
study of 98 patients, Chaudhary et al [9] reported similar pain, ROM, function, quality 210 
of life scores and complication rates between CR and PS groups after a follow-up of 2 211 
years. Clark et al [26], in other randomized study of 143 patients with a minimum 2-212 
year follow-up reported no significant differences between groups regarding to 213 
functional scores or ROM. On the contrary, other randomized studies found significant 214 
clinical differences. 215 
Maruyama et al [27], in a randomized comparison of 20 patients whom were bilaterally 216 
operated with both CR and PS designs reported similar knee scores but higher range of 217 
motion in the PS knees after a mean follow-up of 2 years. Harato et al [10], in a 218 
multicenter randomized study of 99 CR patients and 99 PS patients with a minimum 219 
follow-up of 5 years, found no significant differences between both groups in functional 220 
outcomes, satisfaction or complication rate, but improvement in range of motion was 221 
better in the PS group. Ozturk et al [11], comparing randomly 33 CR patients and 28 PS 222 
patients with a deformity greater than 10º and follow-up of 7 years, reported that both 223 
types of prosthesis produced similarly successful functional outcomes but flexion arc 224 
was larger in PS knees. Overall, a recent meta-analysis of randomized controlled trials 225 
[2] found similar clinical outcomes with regard to knee function, pain, ROM and 226 
complications between CR and PS designs. 227 
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To our knowledge, only 3 studies have reported on the comparative clinical outcomes 228 
with follow-up over 10 years [13-15] and with controversial findings. In agreement with 229 
us, Mayne et al [15] found similar functional scores, ROM and revision rate between 230 
both designs. Likewise, Beaupre et al [13] found no differences in functional outcomes 231 
or revisions, although ROM data were not reported. On the contrary, other long-term 232 
study de 414 patients [14] reported significantly better functional outcomes and ROM 233 
with the PS design, although excellent 10-year survival was also reported for both 234 
designs. However, although clinical score differences were significant, to our 235 
understanding those differences in numbers were small. On the other hand, other large 236 
retrospective study [28], showed a significant difference in TKA survival at 15-year 237 
between CR and PS designs (90% versus 77%), although unfortunately they did not 238 
report functional results. 239 
Strengths of the present study were the relatively large number of patients from a single 240 
center, follow-up over 10 years, and relatively low rate of loss of follow-up. To our 241 
knowledge, this was one of the largest studies on comparative long-term outcomes 242 
published to date. However, the study was not according to usual practice because 243 
patients with severe knee deformity were excluded. Moreover, inherent to any long-244 
term study involving elderly patients, there were 13% of patients losses to follow-up. 245 
In addition, this study had other limitations. First, this study was limited by its 246 
retrospective design. Our patient cohorts were not randomized and patient selection bias 247 
may have occurred. On the other hand, our findings could be specific to the implant 248 
used and not be generalized to other arthroplasty systems. In addition, CR model was 249 
hybrid whereas the PS was cemented which could be a confounding factor on outcomes 250 
or longevity of the prosthesis. 251 
 252 
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CONCLUSIONS 253 
The present study demonstrated successful survival for both designs with similar 254 
clinical outcomes between CR and PS designs at long-term follow-up. Thus, the 255 
superiority of one design over the other was not found. Both designs can be used 256 
expecting long-term successful outcomes and high survival. The choice of the design 257 
depended on the status of the posterior cruciate ligament and surgeon preference. 258 
Currently, we prefer the CR design whether the ligament is sufficient because it requires 259 
less bone resection. 260 
 261 
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LEGEND OF FIGURE 354 
Fig. 1. Kaplan-Meier cumulative survival curves (p= 0.209) 355 
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Table 1. Baseline characteristics at the time of the TKA 360 
 CR group 
n= 268 
PS group 
n= 211 
p-value 
Age at TKA 68.8 (7.1) 70.1 (8.3) 0.108 
Gender (F/M) 196/72 144/67 0.142 
BMI 31.6 (5.2) 32.5 (5.8) 0.118 
Alignment pre 4.2º (4.8º) VR 4.6º (5.1º) VR 0.438 
KSS-knee 35.9 (14.6) 36.4 (15.2) 0.746 
KSS-function 45.3 (15.9) 47.2 (14.7) 0.229 
ROM 91.6 (12.4) 90.8 (13.5) 0.553 
Flexion 94.4 (10.7) 92.6 (11.3) 0.116 
Extension lag 3.2 (3.4) 3.3 (3.7) 0.787 
Global WOMAC 40.6 (9.2) 39.8 (8.7) 0.387 
SF12-physical 21.5 (5.7) 20.8 (6.1) 0.255 
SF12-mental 42.4 (9.8) 41.6 (9.6) 0.426 
Continuous data as mean (SD). Alignment, preoperative. VR: varus femorotibial 361 
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Table 2. Functional outcomes over the time  364 
 CR group  PS group   p          
KSS-knee  
   At 5 years 
   At final follow-up 
   p 
 
88.3 (6.4) 
86.4 (7.1) 
0.015 
 
87.7 (6.9) 
85.2 (7.6) 
0.001 
 
0.382 
0.117 
KSS-function 
   At 5 years 
   At final follow-up 
   p 
 
88.1 (8.4) 
84.4 (9.1) 
0.001 
 
87.9 (9.3) 
85.6 (9.8) 
0.029 
 
0.826 
0.223 
 
ROM 
   At 5 years 
   At final follow-up 
   p 
 
104.3 (9.7) 
101.2 (10.4) 
0.001 
 
102.9 (10.1) 
100.7 (10.7) 
0.054 
 
0.174 
0.648 
 
Flexion 
   At 5 years 
   At final follow-up 
   p 
 
105.2 (10.9) 
101.3 (11.1) 
0.001 
 
103.1 (11.4) 
100.4 (9.6) 
0.020 
 
0.069 
0.399 
 
Extension lag 
   At 5 years 
   At final follow-up 
   p 
 
1.0 (1.6) 
1.4 (1.8) 
0.016 
 
1.3 (1.4) 
1.2 (1.9) 
0.585 
 
0.056 
0.299 
 
Data as mean (SD). KSS: Knee Society score.  365 
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 367 
Table 3. Patient-reported outcomes over the time 368 
 CR group  PS group   p          
Global WOMAC 
   At 5 years 
   At final follow-up 
   p 
 
84.4 (19.2) 
82.2 (20.1) 
0.249 
 
86.7 (20.2) 
83.3 (19.6) 
0.120 
 
0.262 
0.592 
 
SF12-physical 
   At 5 years 
   At final follow-up 
   p 
40.6 (7.2) 
38.2 (8.1) 
0.001 
41.8 (8.1) 
36.9 (8.9) 
0.001 
 
0.134 
0.143 
 
SF12-mental 
   At 5 years 
   At final follow-up 
   p 
 
49.4 (7.4) 
44.1 (8.2) 
0.001 
 
48.8 (7.9) 
43.4 (9.3) 
0.001 
 
0.446 
0.445 
 
VAS-satisfaction 
   At final follow-up 
 
7.9 (1.9) 
 
7.6 (2.1) 
 
0.151 
Data as mean (SD). Global WOMAC: amount of pain and physical function. VAS: 369 
visual analogue scale for patient satisfaction. 370 
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